Image Reconstruction Technology Utilizes GPUs to Speed Up CT Scanner Workflows
By MedImaging staff writers Posted on 23 Apr 2008 |
Advanced image reconstruction technology has recently been developed for the medical imaging, security, and nondestructive testing markets.
Image reconstruction for computed tomography (CT) scanners frequently takes hours of processing time and represents a major obstacle to efficiency for many organizations. The AxRecon system reduces the time required to complete this work from hours to minutes to speed up imaging workflow. Acceleware Corp. (Calgary,AB,Canada), a leading developer of acceleration solution for high-performance computing, developed the system. AxRecon was recently presented at the European Congress of Radiology (ECR) in March 2008, held in Vienna, Austria.
"Our entry into the medical and commercial imaging market space represents a significant growth opportunity for Acceleware, and is consistent with Acceleware's long-term growth strategy to tackle new markets,” said Sean Krakiwsky, CEO of Acceleware. "The benefits of higher throughput and image quality that are already being realized by early customers of AxRecon will help us drive adoption of this product within the broader imaging market.”
The long processing time required for CT image reconstruction limits throughput and quality for companies, clinicians, and researchers. To meet the demands of their workload, these users frequently forfeit image quality to save on processing time. AxRecon works with existing cone beam CT scanners to eliminate the bottleneck by significantly speeding up filtered back projection computations. This enables medical and commercial users to accelerate the reconstruction of their data and improve the quality of their images without disrupting their current workflow.
The AxRecon system combines Acceleware's proprietary software acceleration libraries with the massive parallel processing power of NVIDIA (Santa Clara, CA, USA) graphic processing units (GPUs) to dramatically increase the speed of sophisticated computations. AxRecon integrates with existing CT scanners with minimal setup. By accelerating algorithms such as filtered back-projection image reconstruction, clients are able to increase the speed of their operations and quality of their end results, while reducing the energy use and physical footprint of their high performance computing systems.
"In biomedical micro-computed tomography applications, the volume dimensions of our reconstructions have increased dramatically over the past few years,” said David Holdsworth of Robarts Imaging. "During the same period, scan times have also been reduced; this makes cone-beam CT reconstruction time the bottleneck that limits workflow in some situations. GPU-based reconstruction is a cost-effective solution for this task, and we have found that Acceleware's AxRecon product can provide 3D [three-dimensional] reconstructions up to 50 times faster than a single-CPU [central processing unit].”
Acceleware develops and markets systems that enable software vendors to leverage heterogeneous, multi-core hardware environments without having to rewrite their applications for parallel processing. This acceleration abstraction technology results in end-users achieving significant computing speed-ups and migrating vendor applications from single-core processing to multiple-core CPUs, GPUs or other acceleration products.
Acceleware's third-generation multi-board GPU solutions can accelerate simulation and processing algorithms by over 35 times, reducing data processing from multiple hours to minutes.
Related Links:
Acceleware
Image reconstruction for computed tomography (CT) scanners frequently takes hours of processing time and represents a major obstacle to efficiency for many organizations. The AxRecon system reduces the time required to complete this work from hours to minutes to speed up imaging workflow. Acceleware Corp. (Calgary,AB,Canada), a leading developer of acceleration solution for high-performance computing, developed the system. AxRecon was recently presented at the European Congress of Radiology (ECR) in March 2008, held in Vienna, Austria.
"Our entry into the medical and commercial imaging market space represents a significant growth opportunity for Acceleware, and is consistent with Acceleware's long-term growth strategy to tackle new markets,” said Sean Krakiwsky, CEO of Acceleware. "The benefits of higher throughput and image quality that are already being realized by early customers of AxRecon will help us drive adoption of this product within the broader imaging market.”
The long processing time required for CT image reconstruction limits throughput and quality for companies, clinicians, and researchers. To meet the demands of their workload, these users frequently forfeit image quality to save on processing time. AxRecon works with existing cone beam CT scanners to eliminate the bottleneck by significantly speeding up filtered back projection computations. This enables medical and commercial users to accelerate the reconstruction of their data and improve the quality of their images without disrupting their current workflow.
The AxRecon system combines Acceleware's proprietary software acceleration libraries with the massive parallel processing power of NVIDIA (Santa Clara, CA, USA) graphic processing units (GPUs) to dramatically increase the speed of sophisticated computations. AxRecon integrates with existing CT scanners with minimal setup. By accelerating algorithms such as filtered back-projection image reconstruction, clients are able to increase the speed of their operations and quality of their end results, while reducing the energy use and physical footprint of their high performance computing systems.
"In biomedical micro-computed tomography applications, the volume dimensions of our reconstructions have increased dramatically over the past few years,” said David Holdsworth of Robarts Imaging. "During the same period, scan times have also been reduced; this makes cone-beam CT reconstruction time the bottleneck that limits workflow in some situations. GPU-based reconstruction is a cost-effective solution for this task, and we have found that Acceleware's AxRecon product can provide 3D [three-dimensional] reconstructions up to 50 times faster than a single-CPU [central processing unit].”
Acceleware develops and markets systems that enable software vendors to leverage heterogeneous, multi-core hardware environments without having to rewrite their applications for parallel processing. This acceleration abstraction technology results in end-users achieving significant computing speed-ups and migrating vendor applications from single-core processing to multiple-core CPUs, GPUs or other acceleration products.
Acceleware's third-generation multi-board GPU solutions can accelerate simulation and processing algorithms by over 35 times, reducing data processing from multiple hours to minutes.
Related Links:
Acceleware
Latest Imaging IT News
- New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
- Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
- AI-Based Mammography Triage Software Helps Dramatically Improve Interpretation Process
- Artificial Intelligence (AI) Program Accurately Predicts Lung Cancer Risk from CT Images
- Image Management Platform Streamlines Treatment Plans
- AI-Based Technology for Ultrasound Image Analysis Receives FDA Approval
- AI Technology for Detecting Breast Cancer Receives CE Mark Approval
- Digital Pathology Software Improves Workflow Efficiency
- Patient-Centric Portal Facilitates Direct Imaging Access
- New Workstation Supports Customer-Driven Imaging Workflow
Channels
Radiography
view channel
World's Largest Class Single Crystal Diamond Radiation Detector Opens New Possibilities for Diagnostic Imaging
Diamonds possess ideal physical properties for radiation detection, such as exceptional thermal and chemical stability along with a quick response time. Made of carbon with an atomic number of six, diamonds... Read more
AI-Powered Imaging Technique Shows Promise in Evaluating Patients for PCI
Percutaneous coronary intervention (PCI), also known as coronary angioplasty, is a minimally invasive procedure where small metal tubes called stents are inserted into partially blocked coronary arteries... Read moreMRI
view channel
AI Tool Tracks Effectiveness of Multiple Sclerosis Treatments Using Brain MRI Scans
Multiple sclerosis (MS) is a condition in which the immune system attacks the brain and spinal cord, leading to impairments in movement, sensation, and cognition. Magnetic Resonance Imaging (MRI) markers... Read more
Ultra-Powerful MRI Scans Enable Life-Changing Surgery in Treatment-Resistant Epileptic Patients
Approximately 360,000 individuals in the UK suffer from focal epilepsy, a condition in which seizures spread from one part of the brain. Around a third of these patients experience persistent seizures... Read more
AI-Powered MRI Technology Improves Parkinson’s Diagnoses
Current research shows that the accuracy of diagnosing Parkinson’s disease typically ranges from 55% to 78% within the first five years of assessment. This is partly due to the similarities shared by Parkinson’s... Read more
Biparametric MRI Combined with AI Enhances Detection of Clinically Significant Prostate Cancer
Artificial intelligence (AI) technologies are transforming the way medical images are analyzed, offering unprecedented capabilities in quantitatively extracting features that go beyond traditional visual... Read moreUltrasound
view channel.jpeg)
AI-Powered Lung Ultrasound Outperforms Human Experts in Tuberculosis Diagnosis
Despite global declines in tuberculosis (TB) rates in previous years, the incidence of TB rose by 4.6% from 2020 to 2023. Early screening and rapid diagnosis are essential elements of the World Health... Read more
AI Identifies Heart Valve Disease from Common Imaging Test
Tricuspid regurgitation is a condition where the heart's tricuspid valve does not close completely during contraction, leading to backward blood flow, which can result in heart failure. A new artificial... Read moreNuclear Medicine
view channel
Novel Radiolabeled Antibody Improves Diagnosis and Treatment of Solid Tumors
Interleukin-13 receptor α-2 (IL13Rα2) is a cell surface receptor commonly found in solid tumors such as glioblastoma, melanoma, and breast cancer. It is minimally expressed in normal tissues, making it... Read more
Novel PET Imaging Approach Offers Never-Before-Seen View of Neuroinflammation
COX-2, an enzyme that plays a key role in brain inflammation, can be significantly upregulated by inflammatory stimuli and neuroexcitation. Researchers suggest that COX-2 density in the brain could serve... Read moreGeneral/Advanced Imaging
view channel
AI-Powered Imaging System Improves Lung Cancer Diagnosis
Given the need to detect lung cancer at earlier stages, there is an increasing need for a definitive diagnostic pathway for patients with suspicious pulmonary nodules. However, obtaining tissue samples... Read more
AI Model Significantly Enhances Low-Dose CT Capabilities
Lung cancer remains one of the most challenging diseases, making early diagnosis vital for effective treatment. Fortunately, advancements in artificial intelligence (AI) are revolutionizing lung cancer... Read moreIndustry News
view channel
GE HealthCare and NVIDIA Collaboration to Reimagine Diagnostic Imaging
GE HealthCare (Chicago, IL, USA) has entered into a collaboration with NVIDIA (Santa Clara, CA, USA), expanding the existing relationship between the two companies to focus on pioneering innovation in... Read more
Patient-Specific 3D-Printed Phantoms Transform CT Imaging
New research has highlighted how anatomically precise, patient-specific 3D-printed phantoms are proving to be scalable, cost-effective, and efficient tools in the development of new CT scan algorithms... Read more
Siemens and Sectra Collaborate on Enhancing Radiology Workflows
Siemens Healthineers (Forchheim, Germany) and Sectra (Linköping, Sweden) have entered into a collaboration aimed at enhancing radiologists' diagnostic capabilities and, in turn, improving patient care... Read more